Abstract
Background Late gadolinium enhancement (LGE) accurately detects myocardial fibrosis in hypertrophic cardiomyopathy (HCM), which has been recently shown to be an independent risk factor for cardiac events in this setting. Endoglin is an accessory protein for the TGF-b receptor, which stimulates myocardial fibrosis through modulating the response to Angiotensin II. We sought to explore the relationship between the myocardial fibrosis (tissue substrate) as identified by LGE and Endoglin (biomarker) in the setting of HCM. Methods We studied 133 HCM patients (56±16 y, 94 men) using a whole body 1.5 T CMR scanner (Philips Achieva) with 32 channel image aquisition. Vector-ECG gated short axis, two and four chamber cine slices with parallel image aquisition covering the entire left ventricle (LV) were acquired using a regular SSFP sequence. Matched LGE images were acquired after IV Gadolinium DTPA (0.2mmol/kg bodyweight) in all image planes. Two independent observers assessed LV volumes and myocardial mass that were acquired by manual drawing of endoand epicardial borders. LGE was defined as signal intensity increase of >2SD of normal myocardium and after semi-automatic delineation on a commercially available workstation (Philips Viewforum) areas were quantified and expressed as percentage of the previously measured LV mass. Obstruction was determined using echocardiography gradient measurements at rest and under Valsalva. P<0.05 was considered statistically significant. Results 79 patients (59%) exhibited intramural areas of LGE which averaged 7±12% of the LV mass. Patients with LGE had significantly higher levels of Endoglin compared with patients with no LGE lesions (3.8±0.4 vs. 2.4 ±0.3 nl, p=0.018). There was a weak but almost significant correlation between percent of LGE and Endoglin (r=0.16, p=0.06). Endoglin levels however were not related to obstruction (HNCM: 3.7±0.4 vs. 2.8±0.5, p=ns) and were not related to age, gender or LV mass. Conclusions
Highlights
Late gadolinium enhancement (LGE) accurately detects myocardial fibrosis in hypertrophic cardiomyopathy (HCM), which has been recently shown to be an independent risk factor for cardiac events in this setting
Endoglin is an accessory protein for the TGF-b receptor, which stimulates myocardial fibrosis through modulating the response to Angiotensin II
We sought to explore the relationship between the myocardial fibrosis as identified by LGE and Endoglin in the setting of HCM
Summary
Late gadolinium enhancement (LGE) accurately detects myocardial fibrosis in hypertrophic cardiomyopathy (HCM), which has been recently shown to be an independent risk factor for cardiac events in this setting. Endoglin is an accessory protein for the TGF-b receptor, which stimulates myocardial fibrosis through modulating the response to Angiotensin II. We sought to explore the relationship between the myocardial fibrosis (tissue substrate) as identified by LGE and Endoglin (biomarker) in the setting of HCM
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
